Results 191 to 200 of about 189,595 (350)

Comparative evaluation of surgicel and gelfoam in controlling post-extraction bleeding in patients on anticoagulant therapy: a clinical study. [PDF]

BMC Oral Health
Al-Suliman W, Wehbeh I, Al-Hafyan S.
europepmc   +1 more source

Clinical Evaluation of a New Anticoagulant Therapy in Prosthetic Valve Replacement

, 1978
I Sakashita, S. Ohtani, Chiharu Nakamura, Masahiko Washio   +3 more
openalex   +2 more sources

Evaluation of protein C and protein S levels during oral anticoagulant therapy [PDF]

, 1998
April O’Brien, G. Tate, Caroline Shiach   +2 more
openalex   +1 more source

Nonsteroidal Anti‐Inflammatory Drugs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta‐Analysis

Clinical Pharmacology &Therapeutics, EarlyView.
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely used for pain and inflammation but are associated with gastrointestinal (GI) bleeding. While this risk is well established, most studies evaluate NSAIDs as a homogenous class, limiting clinical decision‐making based on individual agent safety.
Abdelrahman G. Tawfik, Ainhoa Gomez‐Lumbreras, Guilherme Del Fiol, Kensaku Kawamoto, Katy E. Trinkley, Thomas Reese, Aubrey Jones, Daniel C. Malone   +7 more
wiley   +1 more source

Assessing the knowledge and awareness of community pharmacists toward direct oral anticoagulant therapy in Saudi Arabia: A cross-sectional study. [PDF]

Medicine (Baltimore)
Basilim A.
europepmc   +1 more source

The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism [PDF]

, 1997
Sam Schulman, S. Granqvist, Margareta Holmström, Anders Carlsson, Per Lindmarker, Peter Nicol, S.‐G. Eklund, Sune Nordlander, Gerd Lärfars, Barbro Leijd, Olle Linder, Enno Loogna, Hans Walter, Stanka Viering, Martin Hjorth, Jonas Boberg   +15 more
openalex   +1 more source

Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance is a critical component of medication safety. Despite rigorous evaluation of new drugs during clinical trials, some adverse effects might only be identified once pharmaceuticals are used by a larger population for a longer duration.
Claire Spahn, Nanase Toda, Blaine Groat, Omar Aimer, Sara Rogers, Akinyemi Oni‐Orisan, Andrew Monte, Nancy Hakooz, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +8 more
wiley   +1 more source

Perforated Hemorrhagic Cholecystitis After Coronavirus Disease 2019 (COVID-19) in a Patient Receiving Anticoagulant Therapy. [PDF]

Cureus
Kinjo R, Uemura M, Ihashi T, Yamanaga S, Yokomizo H.   +4 more
europepmc   +1 more source

Evolution of Left Atrial Thrombus with Anticoagulant Therapy-Follow-up by Transesophageal Echocardiography [PDF]

, 1995
Cheol Ho Kim, Seung Woo Park, Joo Hee Zo, Byung‐Hee Oh, Myoung Mook Lee, Jung Don Seo, Young Woo Lee   +6 more
openalex   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source